Generated by DeepSeek V3.2| bovine respiratory disease | |
|---|---|
| Name | Bovine respiratory disease |
| Synonyms | Shipping fever, bovine respiratory disease complex (BRDC) |
| Field | Veterinary medicine, Animal science |
| Symptoms | Fever, nasal discharge, coughing, rapid breathing, depression |
| Complications | Pneumonia, Septicemia, death |
| Onset | Often within 2-4 weeks of stress event |
| Causes | Multifactorial: viral and bacterial pathogens, environmental stress, host factors |
| Risks | Weaning, transport, commingling, poor ventilation |
| Diagnosis | Clinical signs, auscultation, Ultrasonography, Bacterial culture |
| Prevention | Vaccination, biosecurity, stress reduction, Metaphylaxis |
| Treatment | Antimicrobials, Non-steroidal anti-inflammatory drugs, supportive care |
| Medication | Tulathromycin, Florfenicol, Ceftiofur |
| Prognosis | Variable; mortality can be high in severe outbreaks |
| Frequency | Leading cause of morbidity and mortality in feedlot cattle |
| Deaths | Significant cause of economic loss |
Bovine respiratory disease is a major health and economic challenge for the global beef and dairy industries. It is a complex, multifactorial syndrome primarily affecting the lower respiratory tract of cattle, often culminating in severe Pneumonia. The condition is most prevalent in young stock within high-density production systems, such as feedlots and dairy calf-rearing facilities, where it is the leading cause of illness and death.
The syndrome represents a final common pathway of disease resulting from a detrimental interaction between infectious agents, environmental stressors, and the host animal's immune status. It is frequently triggered by stressful management events common in modern production, such as long-distance transport to a Feedlot, Weaning, and commingling with animals from diverse origins. This complex etiology has led to its common designation as bovine respiratory disease complex, or shipping fever, particularly when outbreaks follow transportation. Major research and diagnostic efforts are coordinated by institutions like the United States Department of Agriculture and colleges of Veterinary medicine worldwide.
The disease is initiated by a combination of viral pathogens that damage the respiratory epithelium, followed by secondary bacterial invasion of the Lung. Primary viral agents include Bovine herpesvirus 1 (causing Infectious bovine rhinotracheitis), Bovine viral diarrhea virus, Bovine respiratory syncytial virus, and Parainfluenza virus 3. Key bacterial pathogens involved are Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. Critical risk factors that suppress immunity and facilitate infection include the stress of Weaning, transportation, extreme weather fluctuations, poor ventilation in housing, high stocking density, and comingling at auction markets like the Calgary Stampede or National Western Stock Show.
Affected cattle typically exhibit a range of signs including depression, anorexia, fever, increased respiratory rate, nasal discharge, and a moist cough. Severe cases may progress to open-mouth breathing and death. Diagnosis is based on history, clinical examination, and diagnostic tools. Auscultation of the lungs may reveal abnormal sounds, while advanced imaging like thoracic Ultrasonography can consolidate the diagnosis. Confirmation of causative agents often requires Bacterial culture and Polymerase chain reaction testing on samples obtained via Transtracheal wash or post-mortem examination, with laboratories such as those at the University of California, Davis or Kansas State University providing specialized services.
Standard treatment involves the prompt administration of broad-spectrum antimicrobials effective against the common bacterial pathogens. Commonly used products include Tulathromycin, Florfenicol, Ceftiofur, and Enrofloxacin. Supportive care with Non-steroidal anti-inflammatory drugs like Flunixin or Ketoprofen is critical to reduce fever and inflammation. In outbreak situations, Metaphylaxis—the mass medication of an at-risk group—is a common management strategy. Adequate hydration, nutrition, and isolation of sick animals in a hospital pen are essential components of clinical management protocols developed by organizations like the American Association of Bovine Practitioners.
Prevention strategies are multifaceted, focusing on reducing stress, enhancing immunity, and minimizing pathogen exposure. Vaccination programs against major viral and bacterial components are widespread, utilizing products from companies like Zoetis and Merck & Co.. Optimal management practices include implementing low-stress weaning techniques, ensuring excellent ventilation in barns, providing adequate nutrition, and maintaining an appropriate Biosecurity protocol to limit disease introduction. Pre-conditioning programs before transport and the use of Metaphylaxis upon arrival at a feedlot are standard control measures in the North American beef industry.
The disease imposes a substantial financial burden on cattle producers globally. Direct costs arise from mortality, treatment expenses, and reduced performance in surviving animals. Indirect costs include prevention programs, labor, and the economic loss from condemned carcasses at slaughter. In the United States, economic losses in the feedlot sector alone are estimated to exceed one billion dollars annually. The impact extends to international trade and production efficiency, making it a priority research area for entities like the Food and Agriculture Organization and national research agencies.
Category:Animal diseases Category:Cattle Category:Veterinary medicine